Icu Medical (ICUI) EV to EBITDA (2009 - 2026)

Icu Medical (ICUI) has reported EV to EBITDA for 18 consecutive years, with 86.07 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBITDA fell 69.24% year-over-year to 86.07; the trailing twelve-month figure through Jun 2026 stood at 46.74 (up 9.5% YoY), and the FY2025 full-year result was 75.05, down 7.76% from the prior year.
• EV to EBITDA slipped to 86.07 in Q2 2026 per ICUI's latest filing, from 216.48 in the prior quarter.
• Across five years, EV to EBITDA topped out at 1484.56 in Q2 2023 and bottomed at 76243.82 in Q2 2022.
• Historically, EV to EBITDA has averaged 5305.65 across 5 years, with a median of 155.5 in 2023.
• The sharpest annual moves came in 2022 and 2025: EV to EBITDA tumbled 67697.38% in 2022, then jumped 515.02% in 2025.
• Over 5 years, EV to EBITDA stood at 16060.4 in 2022, then soared by 98.9% to 176.73 in 2023, then surged by 152.48% to 92.75 in 2024, then surged by 515.02% to 570.41 in 2025, then slumped by 84.91% to 86.07 in 2026.
• According to Business Quant data, EV to EBITDA over the past three periods registered 86.07, 216.48, and 570.41 for Q2 2026, Q1 2026, and Q4 2025 respectively.